{"id":"natrecor-nesiritide","safety":{"commonSideEffects":[{"rate":"11","effect":"Hypotension"},{"rate":"8","effect":"Headache"},{"rate":"7","effect":"Back pain"},{"rate":"5","effect":"Nausea"},{"rate":"5","effect":"Abdominal pain"},{"rate":"4","effect":"Dizziness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Nesiritide mimics the action of endogenous B-type natriuretic peptide (BNP), a hormone released by the heart in response to increased wall stress. By activating natriuretic peptide receptor-A (NPR-A) on vascular smooth muscle and endothelial cells, it causes vasodilation and reduces systemic vascular resistance. This decreases both preload and afterload on the failing heart, improving hemodynamics and reducing dyspnea in acute decompensated heart failure.","oneSentence":"Nesiritide is a recombinant B-type natriuretic peptide that binds to natriuretic peptide receptors to promote vasodilation, reduce cardiac preload and afterload, and increase sodium excretion.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:22:43.284Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute decompensated heart failure with dyspnea at rest or with minimal exertion"}]},"trialDetails":[{"nctId":"NCT05492500","phase":"PHASE2","title":"A Study of Ponsegromab in People With Heart Failure","status":"TERMINATED","sponsor":"Pfizer","startDate":"2022-09-26","conditions":"Heart Failure","enrollment":455},{"nctId":"NCT03878706","phase":"","title":"The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination","status":"RECRUITING","sponsor":"University of Athens","startDate":"2017-11-03","conditions":"Diabetes Mellitus, Type 2","enrollment":240},{"nctId":"NCT07057466","phase":"","title":"Prospective Evaluation of AI-ECG for SHD Detection","status":"RECRUITING","sponsor":"Imperial College London","startDate":"2025-11-04","conditions":"Valvular Heart Disease Stenosis and Regurgitation (Diagnosis), Pulmonary Hypertension (Diagnosis), Heart Failure With Reduced Ejection Fraction (HFrEF; Diagnosis)","enrollment":590},{"nctId":"NCT07096726","phase":"NA","title":"Boston Medical Center Ultrasound Decongestion Study in Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Boston Medical Center","startDate":"2026-04","conditions":"Congestive Heart Failure, Volume Overload","enrollment":200},{"nctId":"NCT06183931","phase":"PHASE3","title":"Study of ALXN2220 Versus Placebo in Adults With ATTR-CM","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2024-01-11","conditions":"Transthyretin Amyloid Cardiomyopathy","enrollment":1181},{"nctId":"NCT06114498","phase":"","title":"Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Medical Research Center for Therapy and Preventive Medicine","startDate":"2023-09-01","conditions":"Heart Failure With Preserved Ejection Fraction, Obesity, Mild, Decompensated Heart Failure","enrollment":240},{"nctId":"NCT05705869","phase":"NA","title":"Targeted Assessment in High-Risk paTients With dIAbetes to ideNtify Undiagnosed Heart Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"NHS Greater Glasgow and Clyde","startDate":"2022-12-22","conditions":"Heart Failure, Diabetes Mellitus, Type 1 Diabetes","enrollment":706},{"nctId":"NCT06237309","phase":"PHASE2","title":"REGN5381 in Adult Participants With Heart Failure With Reduced Ejection Fraction","status":"TERMINATED","sponsor":"Regeneron Pharmaceuticals","startDate":"2024-04-11","conditions":"Heart Failure","enrollment":89},{"nctId":"NCT07272395","phase":"","title":"Right Ventricular Function Changes After CIED Implantation: The RIGHT-CIED Study","status":"RECRUITING","sponsor":"Istanbul University - Cerrahpasa","startDate":"2025-08-15","conditions":"Right Ventricular Dysfunction","enrollment":40},{"nctId":"NCT07232784","phase":"","title":"Serial Measurement of Pancreatic Stone Protein (PSP) for Sepsis Early Detection in ICU Patients","status":"COMPLETED","sponsor":"Fapon Biotech Inc.","startDate":"2024-07-10","conditions":"Adult Patients at High Risk of Sepsis","enrollment":250},{"nctId":"NCT07208877","phase":"","title":"AQT90 FLEX NTproBNP (N-terminal Pro-brain Natriuretic Peptide) 2 Test Kit - Clinical Evaluation Study Protocol - China","status":"NOT_YET_RECRUITING","sponsor":"Radiometer Medical ApS","startDate":"2025-10","conditions":"Diagnostic Tests","enrollment":120},{"nctId":"NCT01754597","phase":"NA","title":"Natriuretic Peptide Concentrations of B-type (BNP) During Anesthesia in Patients Previously Sensitized to Anthracyclines","status":"COMPLETED","sponsor":"Institut Bergonié","startDate":"2009-09","conditions":"Breast Cancer","enrollment":54},{"nctId":"NCT01734135","phase":"NA","title":"Provider Notification for High B-type Natriuretic Peptide Values","status":"COMPLETED","sponsor":"VA Palo Alto Health Care System","startDate":"2010-10","conditions":"Heart Failure","enrollment":115},{"nctId":"NCT07181733","phase":"","title":"BNP in Pediatric Metabolic Syndrome","status":"RECRUITING","sponsor":"Fondazione IRCCS Policlinico San Matteo di Pavia","startDate":"2024-05-08","conditions":"Metabolic Syndrome","enrollment":70},{"nctId":"NCT06254703","phase":"","title":"Venous Excess and Lung Ultrasound During Continuous Kidney Replacement Therapy in Critically Ill Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chulalongkorn University","startDate":"2024-03-01","conditions":"Acute Kidney Failure Stage 3","enrollment":100},{"nctId":"NCT05293366","phase":"","title":"LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions","status":"RECRUITING","sponsor":"Federico II University","startDate":"2022-01-27","conditions":"Long Covid-19","enrollment":100},{"nctId":"NCT03738878","phase":"PHASE4","title":"Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1","status":"TERMINATED","sponsor":"Vanderbilt University Medical Center","startDate":"2018-11-15","conditions":"Hypertension","enrollment":4},{"nctId":"NCT07099859","phase":"PHASE4","title":"Effect of Losartan on the Neurohumoral Axis and Ventricular Remodeling of Patients With Severe Aortic Regurgitation Undergoing Valve Surgery.","status":"RECRUITING","sponsor":"Vitor Emer Egypto Rosa","startDate":"2025-07-01","conditions":"Heart Valve Diseases, Left Ventricle Remodeling, Aortic Regurgitation Disease","enrollment":60},{"nctId":"NCT06745206","phase":"NA","title":"Recombinant Human Brain Natriuretic Peptide for the Recovery Stage of Septic Shock","status":"NOT_YET_RECRUITING","sponsor":"Sichuan Provincial People's Hospital","startDate":"2025-12","conditions":"Sepsis-induced Cardiomyopathy, the Recovery Phase of Septic Shock","enrollment":30},{"nctId":"NCT07086287","phase":"NA","title":"Evaluation of the Efficacy of rhBNP in Patients With Diuretic Resistance After Cardiac Surgery","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Anhui Medical University","startDate":"2025-08-01","conditions":"After Cardiac Surgery, Diuretic Resistance","enrollment":120},{"nctId":"NCT07013344","phase":"","title":"Association of Plasma N-terminal Pro-Brain Natriuretic Peptide Levels With the Burden of Coronary Artery Disease","status":"RECRUITING","sponsor":"IRCCS Ospedale San Raffaele","startDate":"2021-09-01","conditions":"Chronic Coronary Syndrome, Chronic Coronary Total Occlusion, Coronary Arterial Disease (CAD)","enrollment":800},{"nctId":"NCT06963619","phase":"","title":"AQT90 FLEX NTproBNP (N-terminal Pro-brain Natriuretic Peptide) 2 Test Kit - Reference Interval Study Protocol - China","status":"NOT_YET_RECRUITING","sponsor":"Radiometer Medical ApS","startDate":"2025-05","conditions":"Diagnostic Tests","enrollment":240},{"nctId":"NCT04329624","phase":"PHASE3","title":"Effect Levosimendan Administration on Postoperative NT-proBNP in Cardiac Risk Patients","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2020-10-10","conditions":"Cardiovascular Risk Factor","enrollment":230},{"nctId":"NCT02583763","phase":"","title":"Cardiac Displacement From Third Trimester to Early Childhood","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Linkoeping","startDate":"2013-01","conditions":"IUGR, Fetal Growth Retardation, Intrauterine Growth Restriction","enrollment":61},{"nctId":"NCT04749212","phase":"","title":"Perioperative Troponin I and NT Pro-BNP in Lung Resection","status":"COMPLETED","sponsor":"Hospital Universitari Vall d'Hebron Research Institute","startDate":"2021-05-19","conditions":"Cardiac Ischemia, Thoracic Cancer, Complication,Postoperative","enrollment":475},{"nctId":"NCT06664528","phase":"","title":"Cardiovascular Health in Adult Patients With Cancer Exposed to Cardiotoxic Therapies","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2025-02-28","conditions":"Cardiac Toxicity, Cancer","enrollment":300},{"nctId":"NCT05391737","phase":"","title":"Cardiac Function in Swimming-Induced Pulmonary Edema (SIPE)","status":"RECRUITING","sponsor":"Dalarna County Council, Sweden","startDate":"2022-07-06","conditions":"Swimming Induced Pulmonary Edema (SIPE), Pulmonary Edema, Lung Diseases","enrollment":120},{"nctId":"NCT06734416","phase":"","title":"Evaluation of the Role of Brain Natriuretic Peptide in Acute Coronary Syndrome .","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-01-01","conditions":"Acute Coronary Syndromes","enrollment":100},{"nctId":"NCT04050683","phase":"NA","title":"Evaluation of Hemodynamic Parameters Following Transjugular Intrahepatic Portosystemic Shunt (TIPS)","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2019-09-25","conditions":"Refractory Ascites","enrollment":50},{"nctId":"NCT03397966","phase":"PHASE4","title":"Metabolic Effects of Natriuretic Peptide Hormones","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2018-07-01","conditions":"Obesity, Cardiovascular Physiological Phenomena, Metabolism","enrollment":5},{"nctId":"NCT03422991","phase":"NA","title":"Cohort of Heart Failure Patients","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2017-12-15","conditions":"Congestive Heart Failure","enrollment":150},{"nctId":"NCT06691477","phase":"","title":"A Cut-off Value Study of N-terminal Brain Natriuretic Peptide （Chemiluminescence Method）","status":"COMPLETED","sponsor":"Beckman Coulter, Inc.","startDate":"2023-04-10","conditions":"Heart Failure, Acute Coronary Syndromes","enrollment":1104},{"nctId":"NCT06690684","phase":"","title":"Identification and Functional Study of Novel Biomarkers for Cardiovascular Diseases","status":"ENROLLING_BY_INVITATION","sponsor":"Ya-Wei Xu","startDate":"2023-10-17","conditions":"Angiocardiography, Heart Failure, Ischemic Heart Disease","enrollment":300},{"nctId":"NCT05797649","phase":"","title":"Comparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proBNP) and Other Biochemical Gradient Criteria in Distinguishing Heart Failure and Non-heart Failure Related Pleural Effusions (CENTRE Study)","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2023-07-01","conditions":"Pleural Effusion, Heart Failure, Malignant Neoplasm","enrollment":120},{"nctId":"NCT05812248","phase":"","title":"Prediction of Vascular Events After Major Non-Cardiac Surgery : an Observational Prospective Cohort Study","status":"RECRUITING","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2022-07-01","conditions":"Noncardiac Surgery","enrollment":20000},{"nctId":"NCT06569511","phase":"","title":"Predictive Value of NT-proBNP on MACEs After Acute Coronary Syndrome","status":"COMPLETED","sponsor":"Haseki Training and Research Hospital","startDate":"2023-09-01","conditions":"Acute Coronary Syndrome, ST-segment Elevation Myocardial Infarction (STEMI), Non-ST-Segment Elevation Myocardial Infarction (NSTEMI)","enrollment":241},{"nctId":"NCT06145347","phase":"","title":"Correlation Between Preoperative NT-proBNP and Postoperative AKI","status":"COMPLETED","sponsor":"Xijing Hospital","startDate":"2023-07-10","conditions":"Acute Kidney Injury","enrollment":629},{"nctId":"NCT06555757","phase":"","title":"Utilising AI Analysis of Sounds To prEdict heaRt failurE decOmpensation","status":"NOT_YET_RECRUITING","sponsor":"Cambridge University Hospitals NHS Foundation Trust","startDate":"2024-08-15","conditions":"Heart Failure","enrollment":250},{"nctId":"NCT04357964","phase":"","title":"Beige Fat, Energy, and the Natriuretic Peptide System","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2020-04-13","conditions":"Obesity","enrollment":137},{"nctId":"NCT06533124","phase":"NA","title":"Parameters of Cardiac Indices on the Ultrasonic Cardiac Output Monitor As Potential Indicators for Predicting the Achievement of Ultrafiltration Endpoint for Acute Heart Failure Treatment","status":"COMPLETED","sponsor":"Shanghai Tong Ren Hospital","startDate":"2022-01-05","conditions":"Acute Heart Failure","enrollment":40},{"nctId":"NCT05678062","phase":"NA","title":"Point-of-care Ultrasound Abnormalities in Eclampsia","status":"RECRUITING","sponsor":"University of Cape Town","startDate":"2022-11-21","conditions":"Eclampsia","enrollment":70},{"nctId":"NCT04553484","phase":"","title":"Measuring Cardiovascular Performance and Blood Flow Using Common But Never Compared Methods.","status":"COMPLETED","sponsor":"Semler Scientific","startDate":"2020-08-05","conditions":"D012039, D001775","enrollment":657},{"nctId":"NCT03344159","phase":"PHASE4","title":"Spironolactone Therapy in Chronic Stable Right HF Trial","status":"COMPLETED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2018-04-01","conditions":"Chronic Right-Sided Heart Failure, Pulmonary Arterial Hypertension, Pulmonary Hypertension, Primary, 2","enrollment":15},{"nctId":"NCT05352698","phase":"","title":"Validation of B-type Natriuretic Peptide With N-terminal Pro B-type Natriuretic Peptide in Perioperative Risk Assessment","status":"COMPLETED","sponsor":"Jordan Leitch","startDate":"2022-05-01","conditions":"Perioperative Care","enrollment":466},{"nctId":"NCT06463808","phase":"","title":"Effect of Recombinant Human Brain Natriuretic Peptide on Ventricular Remodeling and Cardiac Function in Patients With Acute Anterior Myocardial Infraction Undergoing Percutaneous Coronary Intervention","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2023-05-03","conditions":"Ventricular Remodeling, Myocardial Infarction, Anterior Wall","enrollment":100},{"nctId":"NCT03866148","phase":"NA","title":"Obstructive Sleep Apnoea and Cardiac Arrhythmias","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospitals Coventry and Warwickshire NHS Trust","startDate":"2019-10-03","conditions":"Obstructive Sleep Apnea, Cardiovascular Diseases, Arrhythmia","enrollment":200},{"nctId":"NCT06426368","phase":"","title":"Soluble ST2 in Patients With Heart Failure\"","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-07-01","conditions":"Heart Failure Patients","enrollment":100},{"nctId":"NCT06397404","phase":"","title":"VExUS in Patients With Acute Heart Failure","status":"COMPLETED","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2023-05-18","conditions":"Acute Heart Failure","enrollment":100},{"nctId":"NCT04111094","phase":"","title":"DKK3 for Prognosis and Monitoring of GFR Decline in Heart Failure","status":"COMPLETED","sponsor":"University of Giessen","startDate":"2019-10-14","conditions":"Heart Failure, Chronic Kidney Diseases","enrollment":290},{"nctId":"NCT05745090","phase":"","title":"N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) in Type 2 Diabetes Mellitus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Singapore General Hospital","startDate":"2022-11-10","conditions":"Type2diabetes, Heart Failure, Cardiovascular Complication","enrollment":1200},{"nctId":"NCT06348732","phase":"","title":"Diagnostic and Prognostic Role of Troponin and Brain Natriuretic Peptide in Pediatric Patients With Cardiomyopathy in Correlation to Echocardiography Findings","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-09-01","conditions":"Cardiomyopathies","enrollment":65},{"nctId":"NCT05791617","phase":"","title":"PET/MR in Post Stroke Cardiac Inflammation Study","status":"RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2023-07-01","conditions":"Stroke, Inflammation","enrollment":12},{"nctId":"NCT05859048","phase":"NA","title":"Multidisciplinary Approach for High Risk Patients Leading to Early Diagnosis of Canadians in Heart Failure","status":"RECRUITING","sponsor":"Cardiology Research UBC","startDate":"2024-03-01","conditions":"Heart Failure","enrollment":1360},{"nctId":"NCT06292377","phase":"NA","title":"Better Understanding of Fatigue After STroke","status":"UNKNOWN","sponsor":"Brugmann University Hospital","startDate":"2024-03-01","conditions":"Stroke","enrollment":250},{"nctId":"NCT06194019","phase":"","title":"Evaluation of Volume Status Changes in Children on Regular Hemodialysis at Assiut University Children,s Hospital","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-07-01","conditions":"Volume Status in Chronic Kidney Diseases","enrollment":50},{"nctId":"NCT01434433","phase":"","title":"Alere Triage fs B-type Natriuretic Peptide (BNP) Method Comparison Evaluation","status":"COMPLETED","sponsor":"Alere San Diego","startDate":"2011-07","conditions":"Specimens With BNP Values of 5 to 5000 pg/ml, Triage","enrollment":360},{"nctId":"NCT04014647","phase":"","title":"Measurement Of NT-proBNP to Predict Outcomes in Surgery","status":"SUSPENDED","sponsor":"Julie Dawson","startDate":"2019-09-05","conditions":"Vascular Surgical Procedure","enrollment":200},{"nctId":"NCT06088641","phase":"","title":"Preoperative BNP and MINS in AAA Open Repair","status":"UNKNOWN","sponsor":"Gangnam Severance Hospital","startDate":"2022-01-01","conditions":"Myocardial Injury After Non-cardiac Surgery","enrollment":198},{"nctId":"NCT00484770","phase":"PHASE2","title":"STARBRITE: A Randomized Pilot Trial of BNP-Guided Therapy in Patients With Advanced Heart Failure","status":"COMPLETED","sponsor":"Duke University","startDate":"2003-02","conditions":"Congestive Heart Failure","enrollment":135},{"nctId":"NCT00368147","phase":"","title":"Access Creation for Hemodialysis: Association With Structural Changes of the Heart","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2002-04","conditions":"Arteriovenous Fistula, Arteriovenous Graft, Left Ventricular Hypertrophy","enrollment":84},{"nctId":"NCT03698877","phase":"","title":"Procalcitonin and Brain Natriuretic Peptides in Patients With Chronic Kidney Disease.","status":"COMPLETED","sponsor":"The Rogosin Institute","startDate":"2018-12-26","conditions":"Kidney Failure, Chronic","enrollment":79},{"nctId":"NCT00241098","phase":"PHASE4","title":"The VALIDATE Study of Valsartan for Patients With Early Stage Heart Failure","status":"COMPLETED","sponsor":"Novartis","startDate":"2003-05","conditions":"Hypertension, Congestive Heart Failure","enrollment":37},{"nctId":"NCT05716984","phase":"PHASE4","title":"rhBNP in Type 3 Pulmonary Hypertension","status":"UNKNOWN","sponsor":"Shengjing Hospital","startDate":"2023-04-15","conditions":"Group 3 Pulmonary Hypertension","enrollment":72},{"nctId":"NCT02041663","phase":"NA","title":"Septic cArdiac Deficiency and MenIngococcal seveRe Sepsis","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2012-03-05","conditions":"Meningococcal Infections, Septic Shock, Severe Sepsis","enrollment":35},{"nctId":"NCT05919342","phase":"NA","title":"Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY \"SYMPHONY-HF\"","status":"RECRUITING","sponsor":"NHS Greater Glasgow and Clyde","startDate":"2022-12-22","conditions":"Heart Failure, Cardiovascular Diseases","enrollment":3904},{"nctId":"NCT02923609","phase":"PHASE2","title":"Cell Therapy in HFpEF","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2016-01","conditions":"Heart Failure With Normal Ejection Fraction","enrollment":30},{"nctId":"NCT05408988","phase":"","title":"Neurogenic Myocardial and Lung Injury in SAH Patients","status":"UNKNOWN","sponsor":"Medical University of Silesia","startDate":"2022-01-22","conditions":"Myocardial Injury, Lung Injury, Subarachnoid Hemorrhage","enrollment":30},{"nctId":"NCT05778084","phase":"PHASE4","title":"Effect of Empagliflozin on NT-Pro Brain Natriuretic Peptide in Heart Failure Patients With Reduced Ejection Fraction","status":"UNKNOWN","sponsor":"Alexandria University","startDate":"2022-12-15","conditions":"Heart Failure With Reduced Ejection Fraction","enrollment":60},{"nctId":"NCT05761834","phase":"","title":"FASHION Fabry Disease Hypertrophic Cardiomyopathy and Infammation","status":"UNKNOWN","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2023-01-27","conditions":"Fabry Disease","enrollment":150},{"nctId":"NCT03656354","phase":"","title":"Identification of Heart Failure Patients by Seismocardiography","status":"COMPLETED","sponsor":"Acarix","startDate":"2018-06-29","conditions":"Heart Failure","enrollment":219},{"nctId":"NCT05723315","phase":"NA","title":"Effect of rhBNP on CMD in Patients With STEMI After PPCI","status":"UNKNOWN","sponsor":"Henan Institute of Cardiovascular Epidemiology","startDate":"2023-02-20","conditions":"STEMI","enrollment":160},{"nctId":"NCT02652676","phase":"NA","title":"Reversible Pulmonary Artery Banding as Simplified Management of End-stage Dilated Left Ventriculopathy in Early Life","status":"TERMINATED","sponsor":"Loma Linda University","startDate":"2016-01","conditions":"Acute on Chronic Systolic Congestive Heart Failure","enrollment":4},{"nctId":"NCT04320017","phase":"","title":"Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19","status":"COMPLETED","sponsor":"Groupe Hospitalier Pitie-Salpetriere","startDate":"2020-03-20","conditions":"COVID-19, Myocardial Injury, Myocarditis","enrollment":500},{"nctId":"NCT05662995","phase":"NA","title":"Point-of-care Ultrasound Abnormalities in Early Onset Preeclampsia","status":"UNKNOWN","sponsor":"University of Cape Town","startDate":"2022-11-28","conditions":"Preeclampsia, Pulmonary Edema, Cardiac Function","enrollment":60},{"nctId":"NCT04915118","phase":"","title":"A Study Called NATION-OS to Learn About the Link Between N-terminal proBNP (NT-proBNP) Levels and Medical Problems Due to Heart Failure (HF) in German Patients With HF","status":"COMPLETED","sponsor":"Bayer","startDate":"2021-06-17","conditions":"Heart Failure (HF)","enrollment":169},{"nctId":"NCT05595278","phase":"","title":"Red Cell Distribution Width,,NT-proBNP and cTnT in Acute Myocardial Infraction Patient","status":"UNKNOWN","sponsor":"Sohag University","startDate":"2022-11-13","conditions":"Myocardial Infarction","enrollment":30},{"nctId":"NCT03779646","phase":"PHASE2, PHASE3","title":"Bisoprolol in DMD Early Cardiomyopathy","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2019-01-16","conditions":"Duchenne Muscular Dystrophy, Cardiomyopathy, Dilated","enrollment":42},{"nctId":"NCT03757741","phase":"","title":"Inflammation, Fibrosis and Risk of Recurrence After Atrial Fibrillation Ablation","status":"COMPLETED","sponsor":"Cardio Med Medical Center","startDate":"2019-02-01","conditions":"Atrial Fibrillation, Atrial Inflammation","enrollment":100},{"nctId":"NCT01334801","phase":"","title":"Biomarkers in Aortic Stenosis - B.A.S.S.","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2010-07","conditions":"Aortic Stenosis, Disorder of Prosthetic Cardiac Valve, Aortic Valve Insufficiency","enrollment":378},{"nctId":"NCT03187509","phase":"PHASE4","title":"Weight-Based Torsemide Dosing in Subjects With Heart Failure","status":"COMPLETED","sponsor":"New York City Health and Hospitals Corporation","startDate":"2018-04-17","conditions":"Heart Failure","enrollment":52},{"nctId":"NCT02496260","phase":"","title":"Biomarkers and Cardiac MRI as Early Indicators of Cardiac Exposure Following Breast Radiotherapy","status":"COMPLETED","sponsor":"Henry Ford Health System","startDate":"2015-07","conditions":"Breast Cancer","enrollment":25},{"nctId":"NCT05252065","phase":"","title":"Cardiac Substructure Radiation Dose and Early Clinical Monitoring of Stage N2-3 Non-Small Cell Lung Cancer","status":"UNKNOWN","sponsor":"Guizhou Medical University","startDate":"2022-02-28","conditions":"Non-small Cell Lung Cancer","enrollment":40},{"nctId":"NCT03892031","phase":"","title":"Circulatory Function in Laparoscopic Radical Cystectomy for Bladder Cancer","status":"COMPLETED","sponsor":"RenJi Hospital","startDate":"2018-01-01","conditions":"Circulatory Function, Laparoscopic Radical Cystectomy for Bladder Cancer","enrollment":186},{"nctId":"NCT03142659","phase":"","title":"Evaluation and Management of Heart Failure Patients","status":"RECRUITING","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2017-07-01","conditions":"Heart Failure","enrollment":5000},{"nctId":"NCT05214872","phase":"","title":"The Impact of Selected Factors on the Cardiovascular System in Chronic Kidney Disease","status":"COMPLETED","sponsor":"Poznan University of Medical Sciences","startDate":"2016-03-25","conditions":"Atherosclerosis of Artery, Inflammation, Chronic Kidney Diseases","enrollment":252},{"nctId":"NCT05063903","phase":"","title":"Exercise Capacity in Patients With Fontan Procedure","status":"COMPLETED","sponsor":"Hacettepe University","startDate":"2021-09-20","conditions":"Single-ventricle, Fontan Procedure","enrollment":42},{"nctId":"NCT05111769","phase":"NA","title":"Preliminary Study on the Clinical Effect of Recombinant Human Brain Natriuretic Peptide on Sepsis Complicated With Heart Failure","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2021-12-01","conditions":"Sepsis","enrollment":70},{"nctId":"NCT00759733","phase":"","title":"Evaluation Cardiac Function With Echo and BNP in Obstetrical Patients With/Without Cardiac Disease","status":"WITHDRAWN","sponsor":"State University of New York - Upstate Medical University","startDate":"2008-07","conditions":"Pregnancy, Heart Diseases","enrollment":""},{"nctId":"NCT02993601","phase":"","title":"Feasibility Study of a New Peripheral Oedema Monitor for Heart Failure","status":"COMPLETED","sponsor":"Heartfelt Technologies","startDate":"2017-01-15","conditions":"Heart Failure, Diastolic, Edema Brain, Decompensated Heartfailure","enrollment":70},{"nctId":"NCT04350541","phase":"NA","title":"Effects of HIIT in Tolerance to Exercise of Individuals With HF and Coexisting COPD","status":"SUSPENDED","sponsor":"Universidade Federal de Pernambuco","startDate":"2019-09-01","conditions":"Heart Failure, Chronic Obstructive Pulmonary Disease","enrollment":40},{"nctId":"NCT03908528","phase":"NA","title":"Alpha-Lipoic Acid in Breast Cancer Patients","status":"COMPLETED","sponsor":"Damanhour University","startDate":"2019-03-01","conditions":"Breast Cancer, Chemotherapeutic Toxicity","enrollment":64},{"nctId":"NCT00521976","phase":"","title":"Risk Markers in the Acute Coronary Syndromes","status":"COMPLETED","sponsor":"Helse Stavanger HF","startDate":"2002-11","conditions":"Chest Pain, Coronary Artery Disease, Unstable Angina Pectoris","enrollment":871},{"nctId":"NCT04019600","phase":"","title":"Screening of Pulmonary Hypertension in Methamphetamine Abusers","status":"SUSPENDED","sponsor":"The University of Hong Kong","startDate":"2019-12-23","conditions":"Methamphetamine Abuse, Pulmonary Hypertension","enrollment":200},{"nctId":"NCT03645317","phase":"NA","title":"Avoiding Cardiac Toxicity in Lung Cancer Patients Treated With Curative-intent Radiotherapy","status":"UNKNOWN","sponsor":"Prof Corinne Faivre-Finn","startDate":"2019-06-12","conditions":"Lung Cancer","enrollment":200},{"nctId":"NCT04963699","phase":"","title":"The Study of NT-proBNP Combined With HS-cTnT in Evaluating the Prognosis of Sepsis","status":"COMPLETED","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2021-05-26","conditions":"Sepsis","enrollment":80},{"nctId":"NCT04929366","phase":"NA","title":"Is Hemodialysis Associated With Cardiac Markers Change?","status":"COMPLETED","sponsor":"Ziv Hospital","startDate":"2017-12-18","conditions":"Renal Insufficiency, Chronic","enrollment":45},{"nctId":"NCT04886713","phase":"","title":"Adipose Tissue Inflammation in HFpEF","status":"UNKNOWN","sponsor":"Heart Center Leipzig - University Hospital","startDate":"2019-11-01","conditions":"Heart Failure With Preserved Ejection Fraction, Obesity","enrollment":30},{"nctId":"NCT04811456","phase":"","title":"MultiOrgan Inflammatory Syndromes COVID-19 Related Study","status":"UNKNOWN","sponsor":"Medical University of Warsaw","startDate":"2020-05-25","conditions":"Covid19","enrollment":1000},{"nctId":"NCT01941576","phase":"NA","title":"Effects of rhBNP in Pediatrics After Corrective Repair of Tetralogy Of Fallot","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2013-09-01","conditions":"Congenital Heart Defects, Tetralogy Of Fallot","enrollment":120},{"nctId":"NCT03996759","phase":"","title":"Early Prediction of Sepsis by Using Metabolomics","status":"UNKNOWN","sponsor":"Xi Peng","startDate":"2019-07-10","conditions":"Sepsis","enrollment":200}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"BLOOD PRESSURE DIASTOLIC INCREASED"},{"count":1,"reaction":"MEDICATION ERROR"},{"count":1,"reaction":"NO ADVERSE DRUG EFFECT"},{"count":1,"reaction":"OVERDOSE"}],"_approvalHistory":[],"publicationCount":412,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Natrecor (nesiritide)","genericName":"Natrecor (nesiritide)","companyName":"Scios, Inc.","companyId":"scios-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Nesiritide is a recombinant B-type natriuretic peptide that binds to natriuretic peptide receptors to promote vasodilation, reduce cardiac preload and afterload, and increase sodium excretion. Used for Acute decompensated heart failure with dyspnea at rest or with minimal exertion.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}